Wednesday, February 10, 2010, 1:40PM AEST - The Australian Stockmarket closes in 2 hours and 25 minutes.
To create a watchlist or portfolio of shares, Register

Harvard Bioscience Inc. (HBIO)

 8:00AM AEST: 3.42 USD  Up 0.05 (1.48%)  
 MORE ON HBIO 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Harvard Bioscience, Inc. (NGM:HBIO) Delayed quote dataEdit
Last Trade:3.42 USD
Trade Time: 8:00AM AEST
Change:Up 0.05 (1.48%)
Prev Close:3.37
Open:3.38
Bid:2.92 x 500
Ask:3.90 x 100
1y Target Est:6.00
Day's Range:3.33 - 3.42
52wk Range:2.38 - 4.31
Volume:35,236
Avg Vol (3m):79,938.1
Market Cap:100.78M
P/E (ttm):18.69
EPS (ttm):0.18
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add HBIO to Portfolio   Download Data

 HEADLINES 
•HBIO President David Green to Present January 19, 2010 at Global Investor Day 2010
GlobeNewswire (Wed, Jan 13)
•Better Buy: Harvard Bioscience or Thermo Fisher Scientific?
at Motley Fool (Wed, Dec 9)
•HARVARD BIOSCIENCE INC Files SEC form 8-K/A, Financial Statements and Exhibits
EDGAR Online (Fri, Nov 20)
•HARVARD BIOSCIENCE INC Financials
EDGAR Online Financials (Sat, Nov 14)
•HARVARD BIOSCIENCE INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, Nov 10)
•HARVARD BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
EDGAR Online (Thu, Nov 5)
•HBIO Reports Third Quarter 2009 Revenue Growth of 5% Over Third Quarter 2008
GlobeNewswire (Thu, Nov 5)
•Harvard Bioscience, Inc. Schedules Third Quarter 2009 Conference Call for November 4, 2009
GlobeNewswire (Sat, Oct 24)
•HBIO President David Green to Present At 2009 UBS Global Life Sciences Conference On September 23, 2009
GlobeNewswire (Fri, Sep 11)
•HARVARD BIOSCIENCE INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements a
EDGAR Online (Thu, Sep 10)
More Headlines for HBIO...
 ANALYST 
EPS Est (next year) (Dec-09) :N/A
EPS Est (in 2 years) (Dec-10) :N/A
Avg Rec (current)*:3.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Harvard Bioscience, Inc. develops, manufactures, distributes, and markets apparatus and scientific instruments used in life science research at pharmaceutical and biotechnology companies, universities, and government laboratories worldwide.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
•Latest News•7 Indices